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CD4+ and γδ T Cells are the main 
Producers of IL-22 and IL-17A in 
Lymphocytes from Mycobacterium 
bovis-infected Cattle
Sabine Steinbach, H. Martin Vordermeier & Gareth J. Jones
Gene transcription studies have identified dual roles for the cytokines IL-17A and IL-22 in bovine 
tuberculosis, where they show potential as both predictors of vaccine success and correlates of 
infection. To allow for a detailed investigation of the cell populations responsible for production of these 
cytokines, we have utilised a novel bovine IL-22 specific recombinant antibody for flow cytometry. 
Bovine tuberculin (PPDB) induced greater IL-22 and IL-17A production in Mycobacterium bovis  
(M. bovis)-infected cattle compared to non-infected controls, while PWM-induced cytokine levels were 
similar between the two groups. In M. bovis-infected animals, PPDB specific IL-22 and IL-17A responses 
were observed in both CD4+ T cell and γδ T cell populations. Although both cytokines were detected in 
both cell types, IL-22/IL-17A double producers were rare and confined mainly to the γδ T cell population. 
These results support previous gene transcription studies and extend the observation of increased IL-22 
and IL-17A responses in M. bovis-infected animals to the level of protein production. We were also able 
to characterise the cell populations responsible for these disease-related cytokine responses. The data 
generated can be used to further our understanding of the immunopathology of bovine tuberculosis 
and to produce more sensitive and specific immune-diagnostic reagents.
Mycobacterium bovis (M. bovis), the main causative agent of bovine TB and a member of the M. tuberculosis com-
plex, is capable of causing disease in humans and infecting a wide array of wildlife species, including domestic 
cattle. Bovine TB represents a significant economic animal health problem, where it has been estimated that glob-
ally the disease costs US$3 billion annually1. In Great Britain, the primary screening test for diagnosing bovine TB 
in cattle is the single intradermal comparative cervical tuberculin skin test (SICCT). In addition, the whole blood 
interferon-γ (IFN-γ ) release assay can be used as an ancillary test to the skin test, resulting in improved detection 
of M. bovis-infected cattle. However, despite the current ‘test and cull’ programme in Great Britain, the annual 
number of new herd breakdowns remains high in the West of England and in Wales, resulting in the slaughter of 
over 300,000 cattle in the decade up to 20132. Thus, new control strategies are being investigated, including cattle 
vaccination and improved diagnosis using additional biomarkers of infection. It is hoped that by gaining a better 
understanding of immunity to M. bovis, correlates of immune protection or disease progression can be identified 
that would facilitate the design of effective TB vaccines, improved diagnostic and therapeutic strategies.
The last decade of research in pulmonary immunology has identified key molecules required for pathogen 
detection and clearance, with IL-17A and IL-22 emerging as major effector cytokines3. IL-17A is induced imme-
diately after pulmonary M. bovis bacille Calmette-Guérin (BCG) infection of mice4 and contributes to the host’s 
immune defence by the induction of chemokines and cytokines responsible for the early recruitment of neutro-
phils and granuloma formation4,5. Recent reports have further suggested that this early IL-17A production is 
necessary for driving an effective Th1 immune response and robust IFN-γ production following BCG infection 
of mice6 and co-localisation of CXCR5+ T cells with M. tuberculosis-infected macrophages, an event crucial for 
optimal pathogen control7. IL-17A is also detected at later stages of M. tuberculosis infection in mice, suggest-
ing an important role for Th17 cells in memory or secondary immune responses8–10. Although less well stud-
ied, a protective role for IL-22 has also been suggested. IL-22 from NK cells inhibits the intracellular growth of 
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M. tuberculosis in human macrophages by enhancing phagolysosomal fusion11,12 while human NK cells produc-
ing IL-22 are required for BCG vaccine efficacy12. Indeed, in cattle vaccination/challenge experiments, higher 
levels of IL-17A13,14 and IL-2215 expression seen post vaccination but pre-challenge were positively associated with 
vaccine success (i.e. prevention of pathology) following subsequent challenge with M. bovis.
Although IL-17A production plays a role in host defence against mycobacterial infections, excessive produc-
tion may contribute to immune pathology. Repeated exposure of M. tuberculosis-infected mice to BCG resulted 
in increased IL-17A expression, influx of neutrophils and lung tissue damage, which was abrogated in the pres-
ence of IL-17A-blocking antibodies16. Furthermore, greater IL-17A expression was observed in peripheral blood 
mononuclear cells (PBMC) from M. bovis-infected cattle that developed macroscopic lesions17, and positive asso-
ciations between mycobacterial antigen-induced IL-17A production and lesion severity or mycobacterial burden 
have been demonstrated in cattle experimentally infected with M. bovis18. Indeed, our own gene transcription 
studies demonstrated increased IL-17A and IL-22 mRNA expression in M. bovis-infected cattle following stim-
ulation with PPDB, but not in un-infected controls19, suggesting that both cytokines may be useful biomarkers 
for infection.
In most of the cattle studies detailed above, IL-17A and IL-22 responses were measured from a PBMC popula-
tion, and the precise nature of the cells responsible for producing these cytokines were undefined. Given that both 
cytokines have been implicated as biomarkers for two very different applications: (i) predictors of vaccine success 
and (ii) correlates of infection, it is possible that different cell types may be active in these settings. However, to 
allow for such future investigations, methodologies must first be established that allow detailed characterisation 
of these cellular immune responses to M. bovis antigens. To this end, we have utilised a novel bovine IL-22 specific 
recombinant antibody for use in intracellular flow cytometry, which revealed both CD4+ T cells and γ δ T cells as 
the major producers of IL-17A and IL-22 in the setting of bovine TB.
Results
To characterise the cellular components that respond to stimulation with mycobacterial antigens by producing 
IL-17A and/or IL-22, we developed multiparameter flow cytometry panels. The gating strategy used is shown 
in Fig. 1, which clearly demonstrates the ability of our system to identify and enumerate bovine lymphocytes 
producing IL-22 and IL-17A in response to stimulation with PPDB. These experiments were repeated in a 
larger number of cattle naturally infected with M. bovis (TB reactors) as well as uninfected control animals to 
enumerate the percentage of lymphocytes producing either IL-22 (Fig. 2a) or IL-17A (Fig. 2b). Compared to 
unstimulated cultures (Nil), mitogen (PWM) stimulation of PBMC from either non-infected control animals 
or M. bovis-infected TB reactors resulted in a greater percentage of IL-22 positive lymphocytes, confirming the 
capacity of cattle lymphocytes to produce IL-22 (Fig. 2a). Further, a significant increase in the percentage of 
IL-22 producing lymphocytes was observed in M. bovis-infected TB reactors following stimulation with PPDB. 
Figure 1. Identification of IL-22 and IL-17A production in bovine lymphocytes. PBMC from a TB-reactor 
animal were stimulated with PPDB and flow cytometry analysis performed to enumerate IL-22 and IL-17A 
production. Numbers represent the percentage of single, live bovine lymphocytes producing each cytokine.
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In contrast, no similar increase was observed in control animals following PPDB stimulation, demonstrating that 
IL-22 responses were specific for M. bovis infection. Similar results were also seen for IL-17A responses (Fig. 2b). 
Whereas mitogen stimulation induced significant increases in the percentage of IL-17A producing lymphocytes 
in both control and M. bovis-infected animals, M. bovis antigen stimulation only induced significant responses 
in M. bovis-infected animals.
Having shown that M. bovis antigens induced specific IL-22 and IL-17A responses in PBMC from M. 
bovis-infected cattle, we next identified the cell population responsible for this response. Mitogen stimulation 
induced significant increases in the percentage of IL-22 producing cells in both CD4pos and CD4neg lymphocyte 
populations (Fig. 3a). However, a significantly greater proportion of the IL-22 producing cells were found within 
the CD4pos compared to the CD4neg lymphocyte population (Fig. 3b). Similar to mitogen induced responses, M. 
bovis antigens induced significant increases in the percentage of IL-22 producing cells in both CD4pos and CD4neg 
lymphocyte populations. However, in contrast to mitogen stimulation, no clear dominance of either a CD4pos or 
CD4neg lymphocyte response was observed following antigen-specific stimulation, with responses showing a high 
degree of animal to animal variability. Similar response profiles were observed for IL-17A. Mitogen stimulation 
induced significant increases in IL-17A production in both CD4pos and CD4neg lymphocyte populations (Fig. 3c), 
but this again was dominated by responses in the CD4pos lymphocyte population (Fig. 3d). M. bovis antigens 
induced significant increases in the percentage of IL-17A producing cells in both CD4pos and CD4neg lymphocyte 
populations. However, in contrast to IL-22, a significantly greater proportion of the IL-17A producing cells were 
located within the CD4neg lymphocyte population.
To further define the cellular source of IL-22 and IL-17A, bovine lymphocyte populations were labelled with 
antibodies to CD4, CD8, CD335 and γ δ TCR to identify CD4pos T cells, CD8pos T cells, NK cells and γ δ T cells 
respectively. Representative results are shown in Fig. 4, where PPDB stimulation induced IL-22 production 
in both CD4pos and CD4neg lymphocyte populations (upper row). In addition, IL-22 production was also seen 
in both γ δ TCRpos and γ δ TCRneg populations (2nd row). In contrast, IL-22 production could not be detected 
in CD8pos (3rd row) or in CD335pos (bottom row) lymphocyte populations. Similar response profiles were also 
Figure 2. M. bovis-specific induction of IL-22 and IL-17A protein production. The percentage of bovine 
lymphocytes labelling positive for (a) IL-22 and (b) IL-17A protein in M. bovis-infected (TB reactors) and non-
infected (control) animals. Each symbol represents an individual animal while horizontal lines represent the 
median value. * p < 0.05, * * p < 0.01, * * * p < 0.001, nonparametric ANOVA with Dunn’s Multiple Comparison 
Test.
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observed for IL-17A, where neither CD8pos nor CD335pos lymphocytes produced IL-17A following stimulation 
with mycobacterial antigens. Even in the presence of a strong non-specific stimulus such as PMA/Ionomycin, no 
IL-22 and IL-17A production were seen in the NK cell population, and only traces of these cytokines could be 
detected in CD8+ T cells (data not shown). The lack of IL-22 and IL-17A production in the NK cell and CD8+ T 
cell populations was not due to an inability of these cells to respond to mycobacterial antigens, as PPDB stimula-
tion induced IFN-γ production in these cells (Supplemental Fig. 1).
Given that similar response profiles were observed for IL-22 and IL-17A production, we investigated whether 
these two cytokines were being co-expressed by the same cell. Therefore, flow cytometry was used to identify 
bovine lymphocytes simultaneously producing IL-22 and IL-17A following stimulation with either M. bovis anti-
gens (Fig. 5a, left hand panel) or mitogen (data not shown). The percentage of bovine lymphocytes expressing 
IL-17A only (Fig. 5a left hand panel, upper left quadrant), IL-22 only (Fig. 5a left hand panel, lower right quad-
rant) or IL-17A and IL-22 (Fig. 5a left hand panel, upper right quadrant) are summarised in Fig. 5b. Following 
stimulation with mycobacterial antigens, significantly fewer lymphocytes co-produced IL-17A and IL-22 com-
pared to those singularly producing IL-17A or IL-22. Although a similar trend was also observed following mito-
gen stimulation, the percentage of bovine lymphocytes producing IL-17A only was significantly greater than that 
for IL-22 only or IL-17A IL-22 co-producers. Similar observations were made with IFN-γ , where IL-22 IFN-γ 
co-producers or IL-17A IFN-γ co-producers were rarely detected (data not shown). Given that a minor popu-
lation of IL-22 IL-17A co-producers could be detected, we lastly determined the cell surface phenotype respon-
sible for this response. Bovine lymphocytes co-producing IL-17A and IL-22 were identified (Fig. 5a left hand 
panel, upper right quadrant) and ‘back-gated’ for cell surface expression of CD4 and γ δ TCR (Fig. 5a, right hand 
panel). Following stimulation with mycobacterial antigens, the majority of bovine lymphocytes co-producing 
IL-22 and IL-17A were γ δ T cells (Fig. 5c). In contrast, there was a trend for a greater proportion of IL-22 IL-17A 
co-producers in the CD4pos T cell population following mitogen stimulation, however more animal to animal 
variability was observed. Although the role of CD4pos and γ δ T cells as co-producers was only directly investigated 
in 4 animals (Fig. 5c), analysis of data from other experiments with a greater number of animals confirmed that 
a CD4neg cell population was the major co-producer of IL-22 and IL-17A following PPDB stimulation of cattle 
PBMC (Supplemental Fig. 2, left panel).
Figure 3. M. bovis-specific induction of IL-22 and IL-17A protein production in both CD4pos and CD4neg 
lymphocyte populations. (a,c) The percentage of bovine CD4pos or CD4neg lymphocytes from M. bovis-infected 
animals that label positive for (a) IL-22 and (c) IL-17A production. (b,d) The relative proportion of (b) IL-22 
producers or (d) IL-17A producers that are either CD4pos or CD4neg. Each symbol represents an individual 
animal while horizontal lines represent the median value. (a and c) * p < 0.05, * * p < 0.01, * * * p < 0.001, 
nonparametric ANOVA with Dunn’s Multiple Comparison Test; (b,d) * * * p < 0.001 Paired Students T test.
www.nature.com/scientificreports/
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Discussion
We have previously demonstrated that mycobacterial antigens induce increased gene transcription for the 
cytokines IL-22 and IL-17A in PBMC from M. bovis-infected cattle but not from uninfected controls19. The 
results of this present study not only confirms these findings at the level of protein expression, but also identifies 
both CD4+ and CD4- T lymphocytes as major cell populations within cattle PBMC responsible for the produc-
tion of these cytokines in response to M. bovis antigens. Furthermore, within the CD4- lymphocyte population, 
we identified γ δ T cells as the major source of IL-22 and IL-17A production. As expected, our flow cytometry 
analysis also confirmed that cattle PBMC rarely contained cells co-expressing CD4 and the γ δ T cell receptor 
(data not shown), demonstrating that the cytokine-producing CD4+ T cells and γ δ T cells described in this study 
represented discrete cell populations.
Although studies in mice and humans have shown that populations of both CD4+ T cells and γ δ T cells have 
the capacity to produce IL-22 and IL-17A20,21, similar data for these cell populations in cattle is limited. Using 
qRT-PCR, Ma et al. showed increased expression of IL-22 mRNA levels in purified populations of both cell types 
following stimulation with different mitogens22. With more direct relevance to bovine TB, Aranday-Cortes et al. 
demonstrated that mycobacterial antigens induced IL-22 mRNA expression in a purified population of CD4+ 
T cells from M. bovis infected cattle19. However, in both studies, the analysis of IL-22 expression was limited to 
gene transcription analysis, and the impact of this on actual protein levels was not investigated due to the lack of 
suitable reagents detecting IL-22 protein. With the development of the flow cytometry methods detailed herein, 
we can extend the conclusions from the two earlier studies and show for the first time that both mitogen and M. 
bovis antigen stimulation of bovine cells results in elevated protein levels of IL-22 in both the CD4+ T cell and 
Figure 4. M. bovis-specific induction of IL-22 and IL-17A protein production in γδ T cells but not CD8pos 
lymphocytes or NK cells. PBMC from a TB-reactor animal were stimulated with PPDB and flow cytometry 
analysis performed to enumerate IL-22 and IL-17A production in different lymphocyte populations. Numbers 
represent the percentage of single, live bovine lymphocytes. Data representative of at least 4 independent 
experiments.
www.nature.com/scientificreports/
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γ δ T cell compartments. Furthermore, our results for IL-17A production are in agreement with previous studies 
in M. bovis infected animals, where mycobacterial antigens induced increased IL-17A mRNA19 and protein23 
expression in purified populations of both CD4+ T cells and γ δ T cells.
The demonstration that bovine γ δ T cells are a major cell population in cattle PBMC producing IL-22 follow-
ing stimulation with M. bovis antigens differs from our previous study, where PPDB stimulation induced no IL-22 
mRNA expression in highly purified γ δ T cells19. To investigate this discrepancy, we repeated the experiment by 
Aranday-Cortes et al., but this time used flow cytometry analysis to quantitate the production of IL-22 at the 
protein level. Although PPDB induced IL-22 in purified populations of CD4+ T cells, minimal amounts were 
detected in purified populations of γ δ T cells stimulated in the presence of monocytes or CD1b+ dendritic cells 
to act as APC (data not shown). However, in the same experiment, PPDB stimulation of total PBMC from the 
same animal resulted in production of IL-22 by the γ δ T cell component. Thus, our results investigating protein 
levels are consistent with the previous study19 measuring mRNA expression, and suggest that additional signals 
provided by other cells present in the PBMC population are required to enable γ δ T cells to produce IL-22 in 
Figure 5. A small proportion of IL-22 producing lymphocytes co-produce IL-17A. (a) PBMC from a TB-
reactor animal were stimulated with PPDB and flow cytometry analysis performed to enumerate simultaneous 
production of IL-22 and IL-17A in CD4pos lymphocytes and γ δ T cells. Numbers represent the percentage 
of single, live bovine lymphocytes in each quadrant (left hand panel) or the percentage of IL-22 IL-17A co-
producers expressing CD4 or γ δ TCR (right hand panel). (b) The percentage of lymphocytes producing IL-22, 
IL-17A or both following stimulation with PPDB or PWM. Each symbol represents an individual animal while 
horizontal lines represent the median value. * p < 0.05, * * * p < 0.001, nonparametric ANOVA with Dunn’s 
Multiple Comparison Test. (c) The relative proportion of IL-22 IL-17A co-producers that label with either 
anti-CD4 or anti-γ δ TCR. Each symbol represents an individual animal while horizontal lines represent the 
median value.
www.nature.com/scientificreports/
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response to M. bovis antigens. One such candidate may be IL-2. Elloso et al.24 demonstrated that in vitro prolifera-
tion of purified human γ δ T cells in response to malarial antigens required CD4+ T cell production of a cytokine 
that signaled through the IL-2R, whilst other studies in cattle showed that in vitro activation and proliferation of 
purified γ δ T cells required two signals, one delivered through the presentation of antigen by APC and a second 
delivered by addition of exogenous IL-225,26.
Previous works exploring the relative contribution of distinct cell populations to the overall IL-17A response 
during mycobacterial infections have been conflicting. Whereas data from both mice4,5,10 and human27 stud-
ies identified γ δ T cells as the predominant source of IL-17A production, other groups have shown that in the 
human28–31 and cattle setting23 CD4+ T cells were the major source of IL-17A. Possible factors that may contrib-
ute to these discrepancies include the species studied (e.g. mice, human or cattle), the nature of mycobacterial 
infection (e.g. BCG, M. tuberculosis or M. bovis), the cell source (e.g. lung cells, splenocytes or peripheral blood 
cells), the activating agent (e.g. different mycobacterial antigens or mitogens), and the assay system employed 
(e.g. analysis of complex cell mixtures or purified cell populations). Our results demonstrate that distinct cell 
populations produce IL-22 and IL-17A, and that their relative contribution to the overall cytokine response was 
also influenced by several factors, including the nature of the antigen, the cytokine studied and animal variability 
(Fig. 3). While mitogen stimulation clearly resulted in a significantly greater proportion of IL-22 and IL-17A pro-
ducers found within the CD4+ T cell population, this was not evident following stimulation with mycobacterial 
antigens. Indeed, a CD4 negative population, which we subsequently showed to be γ δ T cells, was the dominant 
cell population producing IL-17A following stimulation with PPDB. In contrast, we did not identify a clear dom-
inance for either the CD4+ or CD4 negative cell population in the IL-22 response, due to a high degree of animal 
variation in IL-22 production in M. bovis-infected cattle. The discovery that γ δ T cells from M. bovis-infected 
cattle produced IL-22 following stimulation with mycobacterial antigens is in contrast to a similar study per-
formed in human TB patients, where IL-22 was expressed exclusively in CD4+ T cells31. Although differences in 
the assay may be a contributing factor (i.e. Scriba et al. stimulated whole blood for 12 hours while in our study we 
stimulated PBMC for 24 hours), our results may also highlight more fundamental species differences in γ δ T cell 
responses between bovine and human TB infection.
The demonstration that mycobacterial antigens induced both IL-17A and IL-22 gene transcription in the 
CD4+ T cell population from M. bovis infected cattle19 led us to speculate that their production would be derived 
from the previously described CD4+ T helper 17 (Th17) cells, a population that has been shown to produce both 
cytokines32. Although we did detect these cytokines in the CD4+ T cell compartment, cells co-expressing IL-17A 
and IL-22 were rarely detected. This may be an artefact of the assay conditions used: we analysed both cytokines at 
the same time whereas it is possible that subtle differences in the kinetics of IL-17A and IL-22 protein production 
exist for this cell population. Alternatively, although bovine CD4+ T cells may retain some features of mouse 
Th17 cells, such as IL-17A production and CCR6 and IL-23R expression33, our results suggest that in the setting 
of mycobacterial infection they do not exhibit the ability to produce IL-22. This appears to be more akin to the 
human setting, where it has been suggested that Th17 cells rarely produce IL-2234. CD4+ T cells expressing IL-22, 
but not IL-17A or IFN-γ , have been described in humans35,36 leading to the classification of a Th22 cell popula-
tion. Thus, we propose that the IL-22 expressing CD4+ T cells identified in our study may represent an analogous 
bovine Th22 population. Our results demonstrating that the majority of bovine CD4+ T cells responding to 
mycobacterial antigens produce distinct non-overlapping IL-17A, IL-22 or IFN-γ responses are similar to that 
previously shown in healthy mycobacteria-exposed humans, where specific IL-17A and IL-22 producing CD4+ T 
cells were distinct from each other and from Th1 cytokine producing cells31.
Although less common, our results also demonstrate the presence of a minor population of bovine lym-
phocytes capable of co-producing both IL-17A and IL-22 following stimulation with mycobacterial antigens. 
Interestingly, these cells were predominately CD4- γ δ TCR+ . These results are similar to that observed in a 
human study, where γ δ T cells capable of producing both IL-22 and IL-17A were detected, although they con-
stituted a rare population within the γ δ T cell repertoire (e.g. only 2.7% of IL-22 producing Vγ 2Vδ 2 T cells also 
produced IL-17A)37. There is increasing evidence that γ δ T cells play an important role in the host defence against 
mycobacterial infections in cattle38. In contrast to humans and mice, γ δ T cells are more abundant in ruminant 
species, representing 10–20% of circulating lymphocytes in adult cattle. Following M. bovis infection, both the 
frequency and activation state of circulating γ δ T cells increase, suggesting an active response to infection39. 
Furthermore, γ δ T cells are one of the first cell populations to accumulate at sites of M. bovis infection40, and 
studies in a xenochimeric SCID-bovine mouse model suggest that this presence is important for proper forma-
tion of the developing granuloma and host survival following M. bovis infection41. One possible mechanism by 
which γ δ T cells may regulate granuloma formation is through the production of IL-17A. IL-17A deficient mice 
fail to develop mature lung granulomas following BCG infection5, and γ δ T cells have been shown to be major 
producers of IL-17A in the lungs of BCG infected mice10. Furthermore, adoptive transfer of IL-17A-producing γ δ 
T cells into IL-17A deficient mice allowed for formation of granulomas5. Given that our results show that bovine 
γ δ T cells from M. bovis-infected cattle produce IL-17A and IL-22, we may speculate that these cells, as shown 
in the mouse model, may also play a similar role in mature granuloma formation during bovine TB. Indeed, a 
recent study demonstrated IL-17A and IL-22 expression with tuberculous lesions in cattle, particularly in early 
lesions42. However, as the same study observed little accumulation of γ δ T cells in early stage granulomas, there 
is still further work required to fully explore this hypothesis. Furthermore, given that cattle exhibit numerous 
sub-populations of γ δ T cells, work is also required in fully characterising the γ δ T cells producing IL-17A and 
IL-22, either singularly or co-producing, during bovine TB infection.
In summary, we report for the first time the existence of IL-22 producing CD4+ T cell and IL-22 and/or 
IL-17A producing γ δ T cell subsets in cattle and their involvement in the immune response to mycobacteria 
in bovine TB infection. Remarkable is the contribution of mycobacteria-specific γ δ T cells as the predominant 
IL-17A producing cell population and the major cell population that co-produced IL-22 and IL-17A. The new 
www.nature.com/scientificreports/
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boIL-22 antibody offers us now the possibility to more closely analyse the IL-22 response in M. bovis infected 
cattle, and to further understand the role of IL-22 in innate and adaptive immunity which could benefit vaccine 
research and therapies for chronic inflammatory diseases. For example, when analysed prior to infection, previ-
ous studies in cattle have implicated vaccine-induced IL-17A13,14 and IL-2215 production as biomarkers capable 
of predicting vaccine success following subsequent infection with M. bovis. Identification of such biomarkers has 
potential impact on the screening of new bovine TB vaccines, allowing for initial gating criteria to be used when 
analysing vaccine-induced immunity that prioritises vaccines driving IL-17A and IL-22 responses for further 
evaluation in more costly vaccine challenge experiments. As we have shown that distinct cell populations are 
capable of producing these cytokines, further studies will be required to re-assess which of these responses are 
induced following vaccination and whether these particular cell populations mediate the association between 
IL-17A or IL-22 cytokine production and vaccine success. If indeed identified, this may lead the way to the 
rational design of bovine TB vaccines preferentially targeting these important cell populations.
Methods
Cattle. All animals were housed at the Animal and Plant Health Agency at the time of blood sampling, 
and procedures were conducted within the limits of a United Kingdom Home office license under the Animal 
(Scientific Procedures) Act 1986, which were approved by the APHA Animal Welfare and Ethical Review Body 
(AWERB) committee. Heparinised blood samples were obtained from naturally M. bovis-infected, SICCT (single 
intradermal cervical comparative tuberculin skin-test) -positive reactors from herds known to have bovine tuber-
culosis. All cattle were also positive in the whole blood IFN-γ assay described elsewhere43. Non-infected control 
cattle were obtained from TB-free herds located in non-endemic areas.
Generation of recombinant boIL-22 monoclonal antibodies. Human recombinant monoclonal 
bivalent Fab antibody fragments were generated using the HuCAL (Human Combinatorial Antibody Library) 
technology (Bio-Rad AbD Serotec, Germany). The HuCAL library of Fab antibodies was screened with the 
recombinant full length bovine IL-22 protein (bovine IL-22 ORF minus signal sequence; aa 34–19022) which was 
expressed as a Fc-fusion protein in the mammalian cell line HKB11 (Bio-Rad AbD Serotec, Germany). Bovine 
IL-22 specific antibody clones were sequenced to identify unique antibodies for expression and purification. 
For our recombinant bivalent boIL-22 antibodies we chose the Fab-dHLX-MH format. These are bivalent Fab 
antibodies containing a heavy chain C-terminal dHLX-dimerisation domain followed by c-myc- and His-6-tag. 
Thirteen recombinant monoclonal antibodies with specificity for recombinant bovine IL-22 were generated. 
These antibody clones were investigated for their ability to detect IL-22 in PBMC of TB-reactor cattle stimulated 
with PPDB or PWM using intracellular flow cytometry. Ten of the IL-22 antibody clones detected IL-22 responses 
in bovine lymphocytes following stimulation with PPDB or PWM (data not shown). The specificity of the anti-
body clones for both recombinant and naturally produced bovine IL-22 were confirmed by use of these antibodies 
as capture antibodies in an IL-22 sandwich ELISA (data not shown). Antibody clone 58 was selected for all future 
experiments based on the intensity of labelling and the percentage of IL-22-positive lymphocytes detected.
PBMC isolation and culture. PBMC were isolated from heparinised cattle blood by density gradient 
centrifugation using Histopaque-1077 (Sigma-Aldrich, UK). Purified PBMC were re-suspended in complete 
cell culture medium (RPMI 1640 containing 2 mM GlutaMax, 25 mM HEPES, 0.1 mM NEAA, 5 × 10−5 M 
β -mercaptoethanol, 100 U/ml penicillin, 100 μ g/ml streptomycin [all from Gibco Life Technologies, UK] and 
10% fetal calf serum [Sigma-Aldrich, UK]) and cultured at a concentration of 2 × 106 cell/ml in the presence 
of bovine tuberculin purified protein derivative (PPDB, 1:100 dilution; Prionics, Switzerland). Control cultures 
containing either complete cell culture medium alone or pokeweed mitogen (PWM, 10 μ g/ml; Sigma, UK) were 
Procedure Cell surface Intracellular
Screening of boil-22 antibody clones 1
°: anti-boCD4-AF647 (CC8, Bio-Rad AbD 
Serotec)
1°: recombinant boil-22 Fab antibody (Bio-Rad AbD Serotec)
2°: polyclonal goat anti-huIgG F(ab’)2-FITC (Bio-Rad AbD Serotec)
CD4+ T cell population 1°: anti-boCD4-AF647
1°: boil-22 Fab antibody (clone 58, Bio-Rad AbD Serotec), 
polyclonal rabbit anti-boIL-17A-biotin (Kingfisher Biotech)
2°: anti-huIgG F(ab’)2-FITC, Streptavidin-PE (BD Pharmingen)
CD8+ T cell 
population
1°: anti-boCD8 (CC63, Bio-Rad AbD 
Serotec)
2°: polyclonal goat anti-muIgG2a-PE 
(Invitrogen)
1°: boil-22 Fab, anti-boIL-17A-biotin
2°: anti-huIgG F(ab’)2-FITC, Streptavidin-AF700 (Invitrogen)
NK cell population
1°: anti-boCD335 (NKp46, AbD Serotec)
2°: polyclonal goat anti-muIgG1-PE 
(Invitrogen)
1°: anti-boIL-22 Fab, anti-boIL-17A-biotin
2°: anti-huIgG F(ab’)2-FITC, Streptavidin-AF700
γ δ T cell population
1°: anti-boγ δ TCR (GB21A, Kingfisher 
Biotech)
2°: polyclonal goat anti-muIgG2b-AF633 
(Invitrogen)
1°: anti-boIL-22 Fab, anti-boIL-17A-biotin
2°: anti-huIgG F(ab’)2-FITC, Streptavidin-PE
IL-22/IL-17A co-producers
1°: anti-boγ δ TCR and anti-boCD4-AF647
2°: polyclonal goat anti-IgG2b-PE-Cy7 
(SouthernBiotech)
1°: anti-boIL-22 Fab, anti-boIL-17A-biotin and anti-bo IFN-γ -PE 
(CC302, Bio-Rad AbD Serotec)
2°: anti-huIgG F(ab’)2-FITC, Streptavidin-AF700
Table 1.  Summary of flow cytometry antibody labelling panelsa. aAntibodies are available from the commercial 
companies listed in the table.
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set up in parallel. PBMC were cultured at 37 oC in the presence of 5% CO2 for 18–21 hours followed by a further 
4 hours in the presence of Brefeldin-A (Sigma).
Flow cytometry. All labelling was performed at 4 °C. Cultured PBMC were washed and labelled for 15 min 
with LIVE/DEAD fixable violet dead cell stain (Invitrogen, UK). Subsequently, cells were washed and sur-
face labelled for 20 min. After a further wash cells labelled with unconjugated antibodies were incubated with 
a fluorochrome-labelled secondary antibody for 20 min. Before intracellular labelling (ICS), cells were washed 
and fixed with 1% formaldehyde (Cytofix, BD Biosciences, UK) over night at 4 °C, treated with Perm/Wash 
(BD Biosciences, UK) buffer according to manufacturer’s instruction and intracellularly labelled with recom-
binant bivalent boIL-22 Fab antibody, polyclonal rabbit anti-boIL-17A-biotin (Kingfisher Biotech, USA) and 
anti-boIFN-γ -PE (clone CC302, Bio-Rad AbD Serotec, UK) individually or in combination for 20 min fol-
lowed by secondary labelling with polyclonal goat anti-huIgG F(ab’)2-FITC (Bio-Rad AbD Serotec, UK) and/
or Streptavidin-fluorochrome for 20 min. The same labelling strategy was used for all antibody panels, which are 
summarised in Table 1. As control for stimulation of the individual cell populations, cells were surface labelled 
as described before and intracellularly labelled with anti-boIFN-γ -PE only (Supplemental Fig. 1). All antibod-
ies were purchased from Bio-Rad AbD Serotec except where stated. Antibodies were pre-titrated to determine 
optimal working concentrations (data not shown). Samples were acquired with a CyAn ADP analyser equipped 
with 405, 488 and 642 nm lasers (Beckman Coulter, USA) using Summit software version 4.3.02. More than 
100,000 singlet live lymphocytes were acquired. Un-labelled, single stained cells and FMO controls were used 
as controls and to calculate compensation. Data analysis was performed using FlowJo version 10.0.7 software 
(TreeStar, USA).
Statistical analysis. Statistical analysis was performed using GraphPad Prism, version 6.04 (GraphPad 
Software, USA). The D’Agostino & Pearson omnibus normality test was used to assess Gaussian distribution, and 
parametric or non-parametric tests used where appropriate.
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